Investec Bank plc has filed a Form 8.5 disclosure under Rule 8.5 of the Takeover Code relating to Advanced Medical Solutions Group Plc (AMS.L).
The filing identifies Investec as acting in an exempt principal trader capacity with recognised intermediary status, dealing in a client-serving role.
Investec holds the position of Advisor and Joint Broker to Advanced Medical Solutions Group plc, establishing its connection to the party named in the disclosure.
The dealings covered by the disclosure were undertaken on 17th June 2026, with the form itself published on 18th June 2026.
On that date, Investec purchased a total of 69,359 ordinary shares in Advanced Medical Solutions Group, with prices ranging from a low of 214p to a high of 215.5p per unit.
Alongside those purchases, Investec also recorded sales of 44,359 ordinary shares, with prices ranging from 216p to 222.5p per unit.
No cash-settled derivative transactions were reported as part of this disclosure, with all relevant fields marked not applicable.
Similarly, no stock-settled derivative transactions, including options or other instruments, were recorded in connection with the dealings.
Investec confirmed there are no indemnity arrangements, option arrangements, or agreements that could serve as an inducement to deal or refrain from dealing in the relevant securities.
The bank also stated that no agreements or understandings exist relating to voting rights or the future acquisition or disposal of securities referenced by any derivative instrument.
The contact named on the disclosure is Abhishek Gawde, reachable at +91-9923757332, as listed in the official filing submitted to the regulatory information service.
Rule 8 of the Takeover Code requires that all public dealing disclosures of this nature be made to a recognised Regulatory Information Service in a timely manner.
